AMGN compared with ALEC: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

ALECAlector, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

ALECAlector, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34· pre 481.17· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

ALECAlector, Inc.

2.28· pre 2.28· delayed

Pre-marketNov 5 '26delayed

Mkt cap$254.6MRevenue$3MQ2 FY26Revenue$21MFY25

Compare

Pre-marketNov 5 '26delayed

AMGNAmgen Inc

ALECAlector, Inc.

478.34pre 481.17delayed

Price

2.28pre 2.28delayed

$258.8B

Mkt cap

$254.6M

Q3 FY26$10.4B

Revenue

$3MQ2 FY26

FY25$36.8B

Revenue

$21MFY25

AMGN478.34vsALEC2.28Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ALEC: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only ALEC 3

ABBVAbbViecustomer

GSKGlaxoSmithKlinecustomer

—Adimabunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

AMGN, solidALEC, dashed